Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

468 ARTíCULOS , VIENDO DEL 46 AL 60

PUBMED

[Myelinosomes: A new pathway of protein quality control]

Yefimova M, Ravel C, Neyroud AS, Béré E, Bourmeyster N.

Med Sci (Paris). 2020 Nov;36(11):1012-1017. doi: 10.1051/medsci/2020173. Epub 2020 Nov 5.

0

0

0

PUBMED

Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation

Zhang S, Ma Y, Feng J.

Neural Regen Res. 2020 Nov;15(11):2143-2153. doi: 10.4103/1673-5374.282264.

0

0

0

PUBMED

Identification of contributing genes of Huntington's disease by machine learning

Cheng J, Liu HP, Lin WY, Tsai FJ.

BMC Med Genomics. 2020 Nov 23;13(1):176. doi: 10.1186/s12920-020-00822-w.

0

0

0

PUBMED

C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside

Mylvaganam S, Earnshaw R, Heymann G, Kalia SK, Kalia LV.

Curr Neuropharmacol. 2020 Nov 16. doi: 10.2174/1570159X18666201116145507. Online ahead of print.

0

0

0

PUBMED

FOXO3 targets are reprogrammed as Huntington's disease neural cells and striatal neurons face senescence with p16(INK4a) increase

Voisin J, Farina F, Naphade S, Fontaine M, Tshilenge KT, Galicia Aguirre C, Lopez-Ramirez A, Dancourt J, Ginisty A, Sasidharan Nair S, Lakshika Madushani K, Zhang N, Lejeune FX, Verny M, Campisi J, El

Aging Cell. 2020 Nov;19(11):e13226. doi: 10.1111/acel.13226. Epub 2020 Nov 6.

0

0

0

PUBMED

Comparative interactomes of HSF1 in stress and disease reveal a role for CTCF in HSF1-mediated gene regulation

Burchfiel ET, Vihervaara A, Guertin MJ, Gomez-Pastor R, Thiele DJ.

J Biol Chem. 2020 Nov 18:jbc.RA120.015452. doi: 10.1074/jbc.RA120.015452. Online ahead of print.

0

0

0

PUBMED

Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease

Venkataraman L, Fair SR, McElroy CA, Hester ME, Fu H.

Stem Cell Rev Rep. 2020 Nov 12:1-22. doi: 10.1007/s12015-020-10068-9. Online ahead of print.

0

0

0

PUBMED

SQSTM1 mutation: Description of the first Tunisian case and literature review

Akkari M, Kraoua I, Klaa H, Benrhouma H, Ben Younes T, Rouissi A, Chaabouni M, Ben Youssef-Turki I.

Mol Genet Genomic Med. 2020 Dec;8(12):e1543. doi: 10.1002/mgg3.1543. Epub 2020 Nov 2.

0

0

0

PUBMED

Catastrophic Antiphospholipid Syndrome: Skin, Eye and Brain Involvement

Sanchez JM, Davila M, Amer R.

Ocul Immunol Inflamm. 2020 Nov 13:1-3. doi: 10.1080/09273948.2020.1830122. Online ahead of print.

0

0

0

PUBMED

The aging brain: impact of heavy metal neurotoxicity

Ijomone OM, Ifenatuoha CW, Aluko OM, Ijomone OK, Aschner M.

Crit Rev Toxicol. 2020 Nov 19:1-14. doi: 10.1080/10408444.2020.1838441. Online ahead of print.

0

0

0

PUBMED

Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models

Cepeda C, Levine MS.

Neuroscientist. 2020 Nov 16:1073858420972662. doi: 10.1177/1073858420972662. Online ahead of print.

0

0

0

PUBMED

MRI findings in juvenile Huntington's disease

Arraj P, Robbins K, Dengle Sanchez L, Veltkamp DL, Pfeifer CM.

Radiol Case Rep. 2020 Nov 6;16(1):113-115. doi: 10.1016/j.radcr.2020.10.041. eCollection 2021 Jan.

0

0

0

PUBMED

Gene Expression Profiling in Huntington's Disease: Does Comorbidity with Depressive Symptoms Matter?

Colpo GD, Rocha NP, Furr Stimming E, Teixeira AL.

Int J Mol Sci. 2020 Nov 11;21(22):8474. doi: 10.3390/ijms21228474.

0

0

0

PUBMED

New developments in Huntington's disease and other triplet repeat diseases: DNA repair turns to the dark side

Lahue RS.

Neuronal Signal. 2020 Nov 16;4(4):NS20200010. doi: 10.1042/NS20200010. eCollection 2020 Dec.

0

0

0

PUBMED

Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies

Wright GEB, Black HF, Collins JA, Gall-Duncan T, Caron NS, Pearson CE, Hayden MR.

Lancet Neurol. 2020 Nov;19(11):930-939. doi: 10.1016/S1474-4422(20)30343-4.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy